Mesoblast (ASX.MSB) Heffx Trading Outlook

Mesoblast (ASX.MSB) Heffx Trading Outlook

Mesoblast (ASX.MSB) Heffx Trading Outlook

Overall, the bias in prices is: Upwards.

Short term: Prices are moving.

Intermediate term: Prices are trending.

Note: this chart shows extraordinary price action to the upside.

The projected upper bound is: 2.00.

The projected lower bound is: 1.21.

The projected closing price is: 1.61.

Candlesticks indicate a bullish trend

A big white candle occurred. This is generally considered bullish, as prices closed significantly higher than they opened. If the candle appears when prices are “low,” it may be the first sign of a bottom. If it occurs when prices are rebounding off of a support area (e.g., a moving average, trendline, or retracement level), the long white candle adds credibility to the support. Similarly, if the candle appears during a breakout above a resistance area, the long white candle adds credibility to the breakout.
During the past 10 bars, there have been 6 white candles and 4 black candles for a net of 2 white candles. During the past 50 bars, there have been 23 white candles and 24 black candles for a net of 1 black candles.

A rising window occurred (where the top of the previous shadow is below the bottom of the current shadow). This usually implies a continuation of a bullish trend.

Mesoblast Momentum Indicators

Momentum is a general term used to describe the speed at which prices move over a given time period. Generally, changes in momentum tend to lead to changes in prices. This expert shows the current values of four popular momentum indicators.

Stochastic Oscillator

One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 89.3519. This is an overbought reading. However, a signal is not generated until the Oscillator crosses below 80 The last signal was a buy 9 period(s) ago.

Relative Strength Index (RSI)

The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 77.68. This is where it usually tops. The RSI usually forms tops and bottoms before the underlying security. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a buy 31 period(s) ago.

Commodity Channel Index (CCI)

The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is 274.This is an overbought reading. However, a signal isn’t generated until the indicator crosses below 100. The last signal was a buy 9 period(s) ago.

MACD

The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a buy 31 period(s) ago.

Mesoblast Summary

MESOBLAST FPO gapped up today (bullish) on normal volume. Possibility of a Runaway Gap which usually signifies a continuation of the trend. Four types of price gaps exist – Common, Breakaway, Runaway, and Exhaustion. Gaps acts as support/resistance.
MESOBLAST FPO is currently 15.2% below its 200-period moving average and is in an upward trend. Volatility is extremely high when compared to the average volatility over the last 10 periods. There is a good possibility that volatility will decrease and prices will stabilize in the near term. Our volume indicators reflect very strong flows of volume into MSB.AX (bullish). Our trend forecasting oscillators are currently bullish on MSB.AX and have had this outlook for the last 14 periods. Our momentum oscillator is currently indicating that MSB.AX is currently in an overbought condition.

Description

Mesoblast Limited is engaged in developing cell-based medicines. The Company’s technology platform is based on specialized cells known as mesenchymal lineage adult stem cells (MLCs). The Company’s allogeneic ‘off-the-shelf’ cell product candidates target advanced stages of diseases, such as cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions. The Company is developing products using mesenchymal precursor cells (MPCs), which are injected directly into a targeted disease area. The Company is developing its product candidates in two tiers: Tier 1 and Tier 2. Its Tier 1 product candidates include MPC-150-IM, MPC-06-ID, MSC-100-IV and MPC-300-IV. The Company’s Tier 2 product candidates include MSC-100-IV for the treatment of biologic refractory Crohn’s disease, MPC-25-IC, MPC-25-Osteo and MPC-CBE. The Company offers its product, TEMCELL, for the treatment of graft versus host disease in children and adults in Japan.
Increase your trading profits by trying Metastocks 30 day free trial.

 

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.

Latest posts by HEFFX Australia (see all)

You must be logged in to post comments :  
CONNECT WITH